Hypercalcemia may develop both spontaneously and as a result of androgen therapy in women with disseminated breast carcinoma. If it develops while on this agent, the drug should be discontinued. Caution is required in administering these agents to patients with cardiac, renal or hepatic disease. Cholestatic jaundice is associated with therapeutic use of anabolic and androgenic steroids. Edema may occur occasionally with or without congestive heart failure. Concomitant administration of adrenal steroids or ACTH may add to the edema. In children, anabolic steroid treatment may accelerate bone maturation without producing compensatory gain in linear growth. This adverse effect may result in compromised adult stature. The younger the child the greater the risk of compromising final mature height. The effect on bone maturation should be monitored by assessing bone age of the wrist and hand every six months. This drug has not been shown to be safe and effective for the enhancement of athletic performance. Because of the potential risk of serious adverse health effects, this drug should not be used for such purpose.
The initial color in vial A is red brown, vial B orange brown for GSO oil and lighter for MCT oil. You can see difference for example between trenbolone where it is bright green. There are two different test agents in each vial, which will react in different way to different chemicals. Any discoloration in vial A or B will also indicate presence of contamination. This is why you need both test vials to confirm presence of steroids and their quality. Some steroids will give different initial color in vial A. This is how you can distinguish them. Nandrolone decanoate (oil based) under UV is mat green for GSO and Arachis oil but lighter green for MCT oil. See the color coding for NPP there is huge difference and there is no doubt if you have deca or NPP.